Bladder Cancer Trial, Recruiting NCT03973671 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Bladder Cancer
Back to Bladder Cancer

Bladder Cancer Trial, Recruiting

NCT03973671
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 90 years old
  • People of any sex (male or female)
  • People who agree to allow their medical and tissue data to be collected for research
  • People who are scheduled to have a surgical procedure called TURBT to remove or examine a bladder tumour
  • People who are scheduled to have their bladder surgically removed (with or without removal of nearby lymph nodes), sometimes called a radical cystectomy
  • People who are scheduled to have a tumour biopsy taken from either a primary tumour or one that has spread to another part of the body
  • People who are scheduled to have a kidney and ureter removed (with or without partial bladder or ureter removal), with or without lymph node removal
  • People who are scheduled to have a tumour removed or examined through an internal camera procedure (endoscopy)
  • People whose cancer has spread to other areas and those secondary tumours are planned to be surgically removed

Who may not be able to join:

  • People who do not agree to allow their medical and tissue data to be collected
  • People who later withdraw their agreement for their medical and tissue data to be used
  • People who decline the treatment that has been planned for them
  • Women who are pregnant or where pregnancy is suspected

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven Joniau, MD, PhD, Assistant Professor

Phone: +3216346687

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 May 2020
Est. completion
1 May 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Progression to MIBC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov